Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Losy

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Folia Morphologica|November 6, 2002
Pecam-1 expression in patients with relapsing-remitting multiple sclerosisAdam Niezgoda, Jacek Losy
Folia Neuropathologica|March 28, 2006
Interleukin-12 in acute ischemic stroke patientsJarosław Zaremba, Jacek Losy
Folia Neuropathologica|May 4, 2004
Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosisAdam Szczuciński, Jacek Losy
Expert Opinion on Investigational Drugs|August 13, 2008
Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseasesAlicja Kalinowska, Jacek Losy
Journal of the Neurological Sciences|January 15, 2015
Immunological differences between classical phenothypes of multiple sclerosisPiotr Iwanowski, Jacek Losy
Journal of Neuroimmunology|October 16, 2010
Emerging disease-modifying oral therapies for multiple sclerosisJacek Losy, Alicja Kalinowska-Łyszczarz
International Journal of Molecular Sciences|December 4, 2012
The role of neurotrophins in multiple sclerosis-pathological and clinical implicationsAlicja Kalinowska-Lyszczarz, Jacek Losy
Folia Morphologica|February 16, 2005
Acute ischaemic stroke increases the erythrocyte sedimentation rate, which correlates with early brain damageJarosław Zaremba, Piotr Skrobański, Jacek Losy
European Neurology|September 11, 2007
CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisoloneAdam Szczuciński, Alicja Kalinowska, Jacek Losy
Sleep Medicine Reviews|December 3, 2014
Restless legs syndrome in multiple sclerosisMariusz Sieminski, Jacek Losy, Markku Partinen
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Folia Morphologica|November 6, 2002
Pecam-1 expression in patients with relapsing-remitting multiple sclerosisAdam Niezgoda, Jacek Losy
Folia Neuropathologica|March 28, 2006
Interleukin-12 in acute ischemic stroke patientsJarosław Zaremba, Jacek Losy
Folia Neuropathologica|May 4, 2004
Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosisAdam Szczuciński, Jacek Losy
Expert Opinion on Investigational Drugs|August 13, 2008
Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseasesAlicja Kalinowska, Jacek Losy
Journal of the Neurological Sciences|January 15, 2015
Immunological differences between classical phenothypes of multiple sclerosisPiotr Iwanowski, Jacek Losy
Journal of Neuroimmunology|October 16, 2010
Emerging disease-modifying oral therapies for multiple sclerosisJacek Losy, Alicja Kalinowska-Łyszczarz
International Journal of Molecular Sciences|December 4, 2012
The role of neurotrophins in multiple sclerosis-pathological and clinical implicationsAlicja Kalinowska-Lyszczarz, Jacek Losy
Folia Morphologica|February 16, 2005
Acute ischaemic stroke increases the erythrocyte sedimentation rate, which correlates with early brain damageJarosław Zaremba, Piotr Skrobański, Jacek Losy
European Neurology|September 11, 2007
CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisoloneAdam Szczuciński, Alicja Kalinowska, Jacek Losy
Sleep Medicine Reviews|December 3, 2014
Restless legs syndrome in multiple sclerosisMariusz Sieminski, Jacek Losy, Markku Partinen
Pageof 6